Shirit Einav
- Hepatology top 2%
- Hepatitis C virus research 16
- Infectious Diseases top 2%
- Viral Infections and Vectors 10
- Virology top 5%
- HIV Research and Treatment 7
- Immunology top 10%
- interferon and immune responses 8
-
- Mosquito-borne diseases and control 21
-
- Hepatitis B Virus Studies 8
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Biochemical and Molecular Research 7
- Co-authors
- Elena BekermanRina Barouch‐BentovJeffrey S. GlennStanford SchorSzu‐Yuan PuGrégory NeveuStephen R. QuakeMenashe Elazar
- Journals
- Antiviral Research (5 papers)Journal of Medicinal Chemistry (4 papers)European Journal of Medicinal Chemistry (4 papers)
- Partner nations
- United StatesBelgiumFrance
In The Last Decade
Shirit Einav
55 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 107
- Hepatology 474
- Infectious Diseases 696
- Virology 172
- Immunology 389
- Public Health, Environmental and Occupational Health 509
Countries citing papers authored by Shirit Einav
This map shows the geographic impact of Shirit Einav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirit Einav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirit Einav more than expected).
Fields of papers citing papers by Shirit Einav
This network shows the impact of papers produced by Shirit Einav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirit Einav. The network helps show where Shirit Einav may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shirit Einav, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 13 | |
| 13 | 2019 | 48 | |
| 14 | 2019 | 23 | |
| 15 | 2019 | 0 | |
| 16 | 2018 | 114 | |
| 17 | 2018 | 76 | |
| 18 | 2017 | 69 | |
| 19 | 2016 | 55 | |
| 20 | 2002 | 66 |
About Shirit Einav
Shirit Einav is a scholar working on Hepatology, Virology, Infectious Diseases, Public Health, Environmental and Occupational Health and Immunology, having authored 59 papers that have together received 2.3k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (21 papers), Hepatitis C virus research (16 papers), Viral Infections and Vectors (10 papers), interferon and immune responses (8 papers), Hepatitis B Virus Studies (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Biochemical and Molecular Research (7 papers) and HIV Research and Treatment (7 papers). The work is most often cited by research in Hepatology (474 citations), Infectious Diseases (696 citations), Virology (172 citations), Immunology (389 citations) and Public Health, Environmental and Occupational Health (509 citations). Shirit Einav has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Elena Bekerman, Rina Barouch‐Bentov, Jeffrey S. Glenn, Stanford Schor, Szu‐Yuan Pu, Grégory Neveu, Stephen R. Quake, Menashe Elazar, Doron Gerber and Ella H. Sklan. Their work appears in journals such as Antiviral Research, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Cell Reports and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.